How does AI reduce denials for infusion and chemotherapy claims?

By checking authorization status, coverage determination rules, and coding conflicts before a claim is submitted, instead of finding them on the remittance advice after the fact. Waste modifiers are also derived automatically from dose and vial-size records rather than relying on a coder to catch them manually.

Can AI help with the CMMI Enhancing Oncology Model or MIPS reporting?

Yes. Continuous electronic patient-reported outcome collection can integrate over FHIR, symptom severity can be pre-classified before the visit, and quality-measure documentation gaps can be flagged at the point of scheduling rather than in a post-encounter report.

Does AI replace oncology billing and coding staff?

No. AI acts as a co-pilot — preparing clean claim drafts and flagging the accounts that need review — so coders and billing staff spend their time on judgment calls instead of re-typing claims from chart notes.

How is AI software for oncology different from general medical billing AI?

General billing automation doesn't know oncology-specific rules like JW/JZ waste modifiers, chemo-regimen authorization patterns, or NCD/LCD medical-necessity criteria for specialty drugs. Oncology-specific AI is built around those rules directly.

What should an oncology practice look for in an AI healthcare platform?

Look for AI applied directly to oncology's highest-risk workflows — drug waste, prior authorization, and medical necessity — rather than a general chatbot layered on top of an unrelated billing system. Ask whether the vendor's automation predates their AI marketing, or whether AI was added once it became a trend.

Oncology & Cancer Care

AI Software for Oncology & Cancer Care

Powered with Artificial Intelligence. Built for Human Intelligence.

Oncology carries some of the highest-dollar, highest-complexity claims in specialty healthcare. Unlimited Systems combines specialty-specific workflows, intelligent automation, predictive technology, and AI to reduce the administrative burden of billing biologic drugs and improve financial performance without adding another tool for your team to manage.

Request Demo Explore Unlimited AI

AI Built Around the Realities of Oncology

Oncology billing complexity isn't hypothetical. A single infusion visit can involve a primary drug code, a sequential code, a hydration line, and a waste modifier — all dependent on details buried in the clinical documentation rather than sitting in a structured field.

High biologic and specialty-drug costs mean a single denied or underpaid claim carries an outsized financial impact.
JW/JZ waste modifiers depend on matching documented dose against vial size — a calculation that's easy to skip under time pressure.
Multi-drug chemotherapy regimens each carry payer-specific prior authorization requirements that shift by plan and by diagnosis.
Medical necessity rules vary by National and Local Coverage Determination, and keeping staff current on every combination is impractical.
Value-based programs like the CMMI Enhancing Oncology Model add continuous quality-measure and cost-tracking requirements on top of standard billing.

Use Cases

Where AI Can Improve Oncology Operations

Problem: Vial residual on single-dose biologics often goes unbilled because the JW waste modifier depends on matching the physician's documented dose against the vial size.
Automation + Intelligence: Waste modifiers are derived automatically from documented dose and vial-size records at charge entry, instead of relying on a coder to catch it after the fact.
Human Benefit: Coders stop manually cross-referencing vial sizes on every biologic claim.
Business Benefit: Reimbursable waste is captured consistently instead of being written off.

Problem: Chemotherapy regimens each carry their own payer-specific authorization requirements, and a missed one surfaces as a denial weeks after the infusion already happened.
Automation + Intelligence: Authorization status is checked against the scheduled regimen ahead of the visit, not after the claim is filed.
Human Benefit: Financial counselors work the regimens missing authorization instead of auditing every regimen scheduled.
Business Benefit: Fewer denials tied to authorization gaps that were preventable before the visit.

Problem: Medical necessity rules for oncology drugs vary by payer, diagnosis, and local coverage determination, and staff can't realistically track every combination.
Automation + Intelligence: Charges are checked against current NCD/LCD and CCI rules automatically before submission.
Human Benefit: Billing staff review the claims that actually fail a rule instead of every claim.
Business Benefit: Fewer medical-necessity denials and less time spent on appeals.

Problem: Programs like the CMMI Enhancing Oncology Model require continuous patient-reported outcome collection and cost tracking that's easy to fall behind on manually.
Automation + Intelligence: ePRO collection integrates over FHIR and symptom severity is pre-classified before the visit, with quality-measure documentation gaps flagged at scheduling.
Human Benefit: Care navigators see which patients need outreach instead of auditing every chart for missing fields.
Business Benefit: Fewer missed quality-measure requirements and a stronger position in value-based contracts.

Problem: A single infusion claim can carry tens of thousands of dollars in drug cost, so a denial or underpayment on one account has an outsized impact on cash flow.
Automation + Intelligence: AR worklists prioritize by dollar value and filing deadline, so the highest-value oncology claims surface first.
Human Benefit: Collectors spend their time on the accounts where a delay is most costly.
Business Benefit: Faster resolution on the claims that matter most to cash flow.

From Automation to Agentic AI

The Evolution of Intelligence in Oncology

Automate

Eligibility and authorization checks run automatically for every scheduled infusion or chemo regimen before the patient arrives.

Identify

Denial patterns by payer and by regimen are flagged early, along with drug-waste opportunities that would otherwise go unbilled.

Prioritize

High-dollar biologic claims and accounts nearing a filing deadline surface ahead of routine, lower-risk claims.

Recommend

A claim missing a required modifier or authorization is flagged with the specific fix needed, not just a rejection code.

Act

Emerging capability: routine, well-defined reauthorization requests for regimens already on file could be initiated automatically — a direction the architecture supports, not a feature live today.

Work by Exception

Work by Exception for Oncology

The scenario

An infusion claim carries an unusual combination of units and a waste modifier that doesn't match the documented vial size for that drug.

How it's handled

Instead of every infusion claim getting the same manual review, only this account — the one with a real discrepancy — is flagged for a coder to check, while the rest of the day's infusion claims move forward.

Human Intelligence

Let AI Handle the Predictable. Let Your Oncology Team Handle What Matters.

Treatment planning, difficult conversations with patients about cost and coverage, and relationships with referring physicians are what an oncology practice's staff are trained for. Automating drug-waste capture, authorization checks, and claim scrubbing gives that time back instead of spending it re-reading charts and re-checking modifiers.

Throughout the Platform

AI Across the Oncology Revenue Cycle

Charge Validation Software

Specialty and payer rules catch charge errors before claims go out the door.

Financial Clearance Software

Eligibility, authorization, and estimates cleared before service is rendered.

Value-Based Care Software

Track quality measures and risk contracts alongside the financial workflow.

AR Management

Work claims by exception with a prioritized, aging-aware worklist.

Why Unlimited Systems for Oncology

Built for oncology's payer complexity, not adapted from a general practice-management platform.
JW/JZ waste-modifier logic and NCD/LCD checks are embedded in charge entry, not a separate audit step.
Connected financial data means EOM and MIPS reporting draw from the same records as billing, not a parallel spreadsheet.
Work by exception means oncology billing staff review the regimens with an actual problem, not every regimen.

Knowledge Base

Frequently Asked Questions About AI for Oncology

AI software for oncology applies automation and predictive intelligence to the revenue cycle tasks specific to cancer care — drug-waste modifier capture, chemo-regimen prior authorization, and NCD/LCD medical-necessity checks — so routine claims move forward and only genuine exceptions require staff review.